RT Journal Article
SR Electronic
T1 Identifying COVID-19 cases in primary care settings
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.26.20182204
DO 10.1101/2020.08.26.20182204
A1 Mao, Yinan
A1 Tan, Yi-Roe
A1 Thein, Tun Linn
A1 Chai, Yi Ann Louis
A1 Cook, Alex R
A1 Dickens, Borame L
A1 Lew, Yii Jen
A1 Lim, Fong Seng
A1 Lim, Jue Tao
A1 Sun, Yinxiaohe
A1 Sundaram, Meena
A1 Soh, Alexius
A1 En Tan, Glorijoy Shi
A1 Wong, Franco Pey Gein
A1 Young, Barnaby
A1 Zeng, Kangwei
A1 Chen, Mark
A1 Seng, Desmond Ong Luan
YR 2020
UL http://medrxiv.org/content/early/2020/09/01/2020.08.26.20182204.abstract
AB Case identification is an ongoing issue for the COVID-19 epidemic, in particular for outpatient care where physicians must decide which patients to prioritise for further testing. This paper reports tools to classify patients based on symptom profiles based on 236 SARS-CoV-2 positive cases and 564 controls, accounting for the time course of illness at point of assessment. Clinical differentiators of cases and controls were used to derive model-based risk scores. Significant symptoms included abdominal pain, cough, diarrhea, fever, headache, muscle ache, runny nose, sore throat, temperature between 37.5°C and 37.9°C, and temperature above 38°C, but their importance varied by day of illness at assessment. With a high percentile threshold for specificity at 0.95, the baseline model had reasonable sensitivity at 0.67. To further evaluate accuracy of model predictions, we firstly used leave-one-out cross-validation, which confirmed high classification accuracy with an area under the receiver operating characteristic curve of 0.92. For the baseline model, sensitivity decreased to 0.56. Secondly, in a separate ongoing prospective study of 237 COVID-19 and 346 primary care patients presenting with symptoms of acute respiratory infection, the baseline model had a sensitivity of 0.57 and specificity of 0.89, and in retrospective notes review of 100 COVID-19 cases diagnosed in primary care, sensitivity was 0.56. A web-app based tool has been developed for easy implementation as an adjunct to laboratory testing to differentiate COVID-19 positive cases among patients presenting in outpatient settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is supported by the Singapore Ministry of Health National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre (NMRC/CG/C026/2017_NUHS) and grant COVID19RF-004.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data collected using structured questionnaires with waiver of consent granted by the Ministry of Health, Singapore under the Infectious Diseases Act.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and codes referred to in the manuscript can be shared upon request. https://sshsphdemos.shinyapps.io/covid-19_calculator_v5/